[
  {
    "ts": null,
    "headline": "Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity",
    "summary": "The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and compliance. Demand is driven by personalized medicine, diagnostic volume growth, and regulatory needs, with a focus on agility and regional adaptation. Blood Collection Tubes Market Blood Collection Tubes Market Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The \"Blood Collection Tubes Market - Global Forecast 2025-2032\" has",
    "url": "https://finnhub.io/api/news?id=3b5190c5c6b4833225dc5e7380a4eac236160557653668559050735b4e84c68c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765552680,
      "headline": "Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity",
      "id": 137769433,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and compliance. Demand is driven by personalized medicine, diagnostic volume growth, and regulatory needs, with a focus on agility and regional adaptation. Blood Collection Tubes Market Blood Collection Tubes Market Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The \"Blood Collection Tubes Market - Global Forecast 2025-2032\" has",
      "url": "https://finnhub.io/api/news?id=3b5190c5c6b4833225dc5e7380a4eac236160557653668559050735b4e84c68c"
    }
  },
  {
    "ts": null,
    "headline": "Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO)",
    "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 13 Best Nanotechnology Stocks to Buy Now. According to The Fly, on December 2, 2025, Morgan Stanley analyst Kallum Titchmarsh established a price objective of $670, up from $656. He initiated coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with an Overweight rating. According to Titchmarsh, the end […]",
    "url": "https://finnhub.io/api/news?id=b2722b24d8281767301cf6dacb9c8f7ed3a537f017dc20f89a5ac0a34fed47cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765547438,
      "headline": "Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO)",
      "id": 137769434,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 13 Best Nanotechnology Stocks to Buy Now. According to The Fly, on December 2, 2025, Morgan Stanley analyst Kallum Titchmarsh established a price objective of $670, up from $656. He initiated coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with an Overweight rating. According to Titchmarsh, the end […]",
      "url": "https://finnhub.io/api/news?id=b2722b24d8281767301cf6dacb9c8f7ed3a537f017dc20f89a5ac0a34fed47cd"
    }
  },
  {
    "ts": null,
    "headline": "Autoimmune Disease Diagnosis Market to Surge to USD 8.98 Billion by 2031",
    "summary": "The autoimmune disease diagnosis market is poised to grow from USD 5.57 billion in 2025 to USD 8.98 billion by 2031, exhibiting a CAGR of 8.3%. Key growth drivers include rising autoimmune disorder prevalence, increased awareness of early detection, and technological advances. Systemic autoimmune diseases lead in market share due to conditions like rheumatoid arthritis and lupus necessitating complex diagnostics. The Asia Pacific region is the fastest-growing, driven by healthcare advancements.",
    "url": "https://finnhub.io/api/news?id=75a71738f8a891e1a7801dd74bcc21e66161a539a32b63b5cb006981f2018af3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765538880,
      "headline": "Autoimmune Disease Diagnosis Market to Surge to USD 8.98 Billion by 2031",
      "id": 137766979,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The autoimmune disease diagnosis market is poised to grow from USD 5.57 billion in 2025 to USD 8.98 billion by 2031, exhibiting a CAGR of 8.3%. Key growth drivers include rising autoimmune disorder prevalence, increased awareness of early detection, and technological advances. Systemic autoimmune diseases lead in market share due to conditions like rheumatoid arthritis and lupus necessitating complex diagnostics. The Asia Pacific region is the fastest-growing, driven by healthcare advancements.",
      "url": "https://finnhub.io/api/news?id=75a71738f8a891e1a7801dd74bcc21e66161a539a32b63b5cb006981f2018af3"
    }
  },
  {
    "ts": null,
    "headline": "Citigroup Upgrades Thermo Fisher Scientific (TMO)",
    "summary": "Citigroup Upgrades Thermo Fisher Scientific (TMO)",
    "url": "https://finnhub.io/api/news?id=bd65a6baac8e5c30a972ca5e54968052d34ab9f2470d7505b0a1b6ab9d5b78ae",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765497999,
      "headline": "Citigroup Upgrades Thermo Fisher Scientific (TMO)",
      "id": 137763186,
      "image": "",
      "related": "TMO",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=bd65a6baac8e5c30a972ca5e54968052d34ab9f2470d7505b0a1b6ab9d5b78ae"
    }
  }
]